📍 NEW YORK, USA
02.11.2026
Scrutiny Mounts Over Clinical Data Verification Following Tavneos Regulatory Action
The regulatory battle between the Food and Drug Administration and the creators of the kidney therapy Tavneos has ignited intense debate across the global biomedical research sector regarding the oversight and auditing o...